Invesco Ltd. Buys 40,099 Shares of Balchem Co. (NASDAQ:BCPC)

Invesco Ltd. lifted its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 21.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 228,933 shares of the basic materials company's stock after acquiring an additional 40,099 shares during the quarter. Invesco Ltd. owned about 0.70% of Balchem worth $37,315,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. HighTower Advisors LLC lifted its stake in Balchem by 15.3% in the 3rd quarter. HighTower Advisors LLC now owns 2,229 shares of the basic materials company's stock worth $391,000 after acquiring an additional 295 shares in the last quarter. Stifel Financial Corp raised its position in shares of Balchem by 26.2% in the third quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company's stock valued at $2,093,000 after purchasing an additional 2,467 shares during the period. Orion Portfolio Solutions LLC boosted its holdings in Balchem by 123.1% during the third quarter. Orion Portfolio Solutions LLC now owns 3,266 shares of the basic materials company's stock valued at $575,000 after acquiring an additional 1,802 shares during the period. Barclays PLC grew its holdings in Balchem by 405.8% in the 3rd quarter. Barclays PLC now owns 60,777 shares of the basic materials company's stock valued at $10,695,000 after buying an additional 48,762 shares during the last quarter. Finally, Westside Investment Management Inc. bought a new stake in Balchem in the 3rd quarter valued at $27,000. 87.91% of the stock is currently owned by institutional investors.

Balchem Stock Up 0.4 %

Shares of Balchem stock traded up $0.58 on Tuesday, reaching $157.50. 338,963 shares of the company were exchanged, compared to its average volume of 130,851. The company has a market capitalization of $5.12 billion, a price-to-earnings ratio of 40.08, a PEG ratio of 4.41 and a beta of 0.75. The company has a 50-day moving average of $164.68 and a 200 day moving average of $167.47. Balchem Co. has a one year low of $137.69 and a one year high of $186.03. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The company had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. On average, equities research analysts forecast that Balchem Co. will post 4.64 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on BCPC shares. HC Wainwright restated a "buy" rating and set a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th. Sidoti upgraded shares of Balchem to a "hold" rating in a research report on Tuesday, February 25th. Finally, StockNews.com downgraded shares of Balchem from a "buy" rating to a "hold" rating in a research report on Tuesday, February 25th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.